Jack Nathan Medical Stock Fundamentals
JNHMF Stock | USD 0.03 0.00 0.00% |
Jack Nathan Medical fundamentals help investors to digest information that contributes to Jack Nathan's financial success or failures. It also enables traders to predict the movement of Jack OTC Stock. The fundamental analysis module provides a way to measure Jack Nathan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jack Nathan otc stock.
Jack |
Jack Nathan Medical OTC Stock Return On Asset Analysis
Jack Nathan's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Jack Nathan Return On Asset | -0.33 |
Most of Jack Nathan's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jack Nathan Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
Based on the latest financial disclosure, Jack Nathan Medical has a Return On Asset of -0.3344. This is 96.18% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The return on asset for all United States stocks is 138.86% higher than that of the company.
Jack Nathan Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jack Nathan's current stock value. Our valuation model uses many indicators to compare Jack Nathan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jack Nathan competition to find correlations between indicators driving Jack Nathan's intrinsic value. More Info.Jack Nathan Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jack Nathan's earnings, one of the primary drivers of an investment's value.Jack Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jack Nathan's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Jack Nathan could also be used in its relative valuation, which is a method of valuing Jack Nathan by comparing valuation metrics of similar companies.Jack Nathan is currently under evaluation in return on asset category among its peers.
Jack Fundamentals
Return On Equity | -1.78 | |||
Return On Asset | -0.33 | |||
Profit Margin | (0.37) % | |||
Operating Margin | (0.30) % | |||
Current Valuation | 6.84 M | |||
Shares Outstanding | 84.33 M | |||
Shares Owned By Insiders | 41.27 % | |||
Price To Book | 4.55 X | |||
Price To Sales | 0.49 X | |||
Revenue | 9.64 M | |||
Gross Profit | 6.66 M | |||
EBITDA | (7.54 M) | |||
Net Income | (7.81 M) | |||
Cash And Equivalents | 816.49 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 106.58 K | |||
Debt To Equity | 0.88 % | |||
Current Ratio | 0.47 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (4.34 M) | |||
Earnings Per Share | (0.08) X | |||
Beta | -1.43 | |||
Market Capitalization | 5.68 M | |||
Total Asset | 8.14 M | |||
Z Score | 32.8 | |||
Net Asset | 8.14 M |
About Jack Nathan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jack Nathan Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jack Nathan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jack Nathan Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Jack Nathan Medical Corp., together with its subsidiaries, operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand. Jack Nathan Medical Corp. was founded in 2006 and is headquartered in Woodbridge, Canada. Jack Nathan is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Jack OTC Stock
Jack Nathan financial ratios help investors to determine whether Jack OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jack with respect to the benefits of owning Jack Nathan security.